Therapeutics Development Center

Detalles del proyecto

Description

We have now enrolled our first subject in Vertex. In addition, we are the first site to be approved by the sponsor to enroll for Nivalis-SNO6 and we screened already screened two subjects and have two more scheduled for screening. We are also ready to enroll for the Solution study and await drug availability on IGNITE.
EstadoFinalizado
Fecha de inicio/Fecha fin1/1/1412/31/16

Financiación

  • Cystic Fibrosis Foundation Therapeutics Incorporated: 90.628,00 US$

Huella digital

Explore los temas de investigación que se abordan en este proyecto. Estas etiquetas se generan con base en las adjudicaciones/concesiones subyacentes. Juntos, forma una huella digital única.